Erica Eggers
YOU?
Author Swipe
View article: An autoantibody signature predictive for multiple sclerosis
An autoantibody signature predictive for multiple sclerosis Open
View article: Feasibility and safety of planned early discharge following laparotomy in gynecologic oncology with enhanced recovery protocol including opioid-sparing anesthesia
Feasibility and safety of planned early discharge following laparotomy in gynecologic oncology with enhanced recovery protocol including opioid-sparing anesthesia Open
Objective This study aims to evaluate the feasibility and safety of planned postoperative day 1 discharge (PPOD1) among patients who undergo laparotomy (XL) in the department of gynecology oncology utilizing a modified enhanced recovery af…
View article: Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cells
Multimodal, broadly neutralizing antibodies against SARS-CoV-2 identified by high-throughput native pairing of BCRs from bulk B cells Open
View article: A Predictive Autoantibody Signature in Multiple Sclerosis
A Predictive Autoantibody Signature in Multiple Sclerosis Open
Although B cells are implicated in multiple sclerosis (MS) pathophysiology, a predictive or diagnostic autoantibody remains elusive. Here, the Department of Defense Serum Repository (DoDSR), a cohort of over 10 million individuals, was use…
View article: Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial
Effect of Ocrelizumab on B- and T-Cell Receptor Repertoire Diversity in Patients With Relapsing Multiple Sclerosis From the Randomized Phase III OPERA Trial Open
This is a substudy (BE29353) of the OPERA I (WA21092; NCT01247324) trial. Date of registration, November 23, 2010; first patient enrollment, August 31, 2011.
View article: Longitudinal analysis of FcRL5 expression and clonal relationships among classical and atypical memory B cells following malaria
Longitudinal analysis of FcRL5 expression and clonal relationships among classical and atypical memory B cells following malaria Open
View article: Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis
Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis Open
Multiple sclerosis is an autoimmune disease of the CNS in which both genetic and environmental factors are involved. Genome-wide association studies revealed more than 200 risk loci, most of which harbour genes primarily expressed in immun…
View article: IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis
IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis Open
IL-17 has been implicated in the pathogenesis of multiple sclerosis (MS). Here, we show that blockade of IL-17A, but not IL-17F, attenuated experimental autoimmune encephalomyelitis (EAE). We further show that IL-17A levels were elevated i…
View article: Longitudinally persistent cerebrospinal fluid B-cells can resist treatment in multiple sclerosis
Longitudinally persistent cerebrospinal fluid B-cells can resist treatment in multiple sclerosis Open
B cells are key contributors to chronic autoimmune pathology in multiple sclerosis (MS). Clonally related B cells exist in the cerebrospinal fluid (CSF), meninges, and CNS parenchyma of MS patients. We sought to investigate the presence of…
View article: Longitudinally persistent cerebrospinal fluid B-cells resist treatment in multiple sclerosis
Longitudinally persistent cerebrospinal fluid B-cells resist treatment in multiple sclerosis Open
B-cells are key contributors to chronic autoimmune pathology in multiple sclerosis (MS). Clonally related B-cells exist in the cerebrospinal fluid (CSF), meninges, and central nervous system (CNS) parenchyma of MS patients. Longitudinally …
View article: Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients
Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients Open
A role of B cells in multiple sclerosis (MS) is well established, but there is limited understanding of their involvement during active disease. Here, we examined cerebrospinal fluid (CSF) and peripheral blood (PB) B cells in treatment-nai…
View article: Onset of secondary progressive <scp>MS</scp> after long‐term rituximab therapy – a case report
Onset of secondary progressive <span>MS</span> after long‐term rituximab therapy – a case report Open
A patient with relapsing multiple sclerosis ( RMS ) was treated with a standard immunomodulatory therapy, but due to ongoing disease activity was switched to rituximab. Relapses ceased, but secondary progressive MS ( SPMS ) eventually appe…